Veradigm Inc.
NASDAQ
Closed
Jul 17, 2026
Day's Range
4.5352 wk Range
3.00Key Statistics
Symbol
MDRX
Name
Veradigm Inc.
Currency
USD
Exchange
NASDAQ
High
4.90000
Low
4.53000
Open
‪4.53‬
Last
‪4.75‬
Market Cap
517.70M
Pe Ratio
‪10.97‬
Volume
1.60K
Average Volume
18.07K
Dividend Yield
‪0.00%‬
Change
-0.15
Percent Change
-3.06
Timestamp
2026-07-17
Close
4.75
Today Range Start
‪4.53‬
Today Range End
‪4.90‬
52 Week Range Start
‪3.00‬
52 Week Range End
‪6.00‬
Type
Stocks
Country
United States
Compliance - MDRX - Veradigm Inc.
Compliance
Status
COMPLIANT
Report Date
2025-02-20
Business Screen
COMPLIANT
Financial Screen
COMPLIANT
Compliant Revenue
‪98.00%‬
Non Compliant Revenue
‪2.00%‬
Questionable Revenue
‪0.00%‬
Securities To Market Cap Ratio
‪10.00%‬
Debt To Market Cap Ratio
‪10.00%‬
Historical Data - MDRX - Veradigm Inc.
Historical Data
Market Cap - MDRX - Veradigm Inc.
Market Cap
2026-07-17
517.70M
2026-07-16
534.05M
2026-07-15
517.70M
2026-07-14
534.05M
2026-07-13
518.79M
2026-07-10
550.40M
2026-07-09
517.70M
2026-07-08
518.79M
2026-07-07
517.70M
2026-07-06
506.80M
Dividend - MDRX - Veradigm Inc.
Dividend
2008-10-13
5.2300
Earnings - MDRX - Veradigm Inc.
Earnings
Balance Sheet - MDRX - Veradigm Inc.
Balance Sheet
| Period Ending | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|
 Assets | 1.50B | 2.31B | 2.91B | 3.20B | 3.18B | 4.23B |
| Liabilities | 487.21M | 950.64M | 1.25B | 1.92B | 1.60B | 3.07B |
| Shareholders Equity | 1.01B | 1.36B | 1.66B | 1.28B | 1.58B | 1.16B |
Cash Flow - MDRX - Veradigm Inc.
Cash Flow
| Period Ending | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|
| Operating Activities | - | - | - | - | - | - |
| Investing Activities | - | - | - | - | - | - |
| Financing Activities | - | - | - | - | - | - |
| End Cash Position | 447.90M | 191.65M | 539.80M | 137.53M | 184.79M | 162.49M |
| Income Tax Paid | - | - | - | - | - | - |
| Interest Paid | - | - | - | - | - | - |
| Free Cash Flow | 83.29M | -118M | -149.04M | -73.51M | -65.90M | 122.41M |
Income Statement - MDRX - Veradigm Inc.
Income Statement
| Period Ending | 2024-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|
| Sales | - | 588.01M | 577.42M | 556.11M | 1.63B | 1.61B |
| Cost of Goods | - | 279.59M | 294.98M | 291.88M | 1.02B | 996.45M |
| Gross Profit | - | 308.42M | 282.44M | 264.23M | 610.28M | 621.39M |
| Operating Expense | - | - | - | - | - | - |
| Operating Income | - | -19.55M | 77.30M | 18.11M | -63.15M | -96.75M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | -42.84M | 93.11M | 3.12M | -175.42M | 85.46M |
| Pre Tax Income | - | -63.85M | 157.70M | -12.56M | -281.75M | -62.19M |
| Income Tax | - | -43.80M | 29.92M | 15.12M | -43.34M | -18.98M |
| Net Income | - | -86.46M | 139.56M | 696.05M | -182.60M | 407.80M |
| EPS Basic | -2.7 | - | 1.03 | 4.37 | -1.1 | 2.07 |
| EPS Diluted | -2.7 | - | 0.97 | 4.37 | -1.1 | 2.04 |
| Basic Shares Outstanding | 108.20M | - | 130.10M | 159.28M | 166.30M | 176M |
| Diluted Shares Outstanding | 108.20M | - | 130.10M | 159.28M | 166.30M | 176M |
| Ebit | - | -57.49M | 170.63M | 21.78M | -238.57M | -11.28M |
| Ebitda | - | 67.33M | 163.61M | 118.84M | -3.16M | 87.93M |
| Net Income Continuous Operations | - | -86.46M | 139.56M | 696.05M | -182.60M | 407.80M |
| Minority Interests | - | - | 0 | 0 | 424K | -44.06M |
| Preferred Stock Dividends | - | - | - | - | - | 48.60M |
Recommendations - MDRX - Veradigm Inc.
Recommendations
Profile - MDRX - Veradigm Inc.
Profile
Mic Code
XNGS
Sector
Healthcare
Industry
Health Information Services
Employees
2.45K
Veradigm Inc. is a healthcare technology company specializing in data-driven solutions that connect providers, payers, and life science organizations. The company’s core offerings include electronic health records (EHR), practice management software, and analytics tools designed to optimize clinical, financial, and operational outcomes. It serves over 180,000 physicians and supports 2,700 hospitals through platforms that enhance care coordination, patient engagement, and population health management. Veradigm leverages its extensive healthcare data network to deliver actionable insights for clinical research, revenue cycle management, and value-based care initiatives. Historically known as Allscripts, the company rebranded in 2023 to reflect its focus on scalable, AI-enhanced solutions. Despite recent regulatory challenges, including a 2024 Nasdaq suspension for delayed financial filings, Veradigm remains a significant player in healthcare IT, bridging gaps across the ecosystem through interoperable technology and data interoperability standards.
Profile Details
Type
Common Stock
Ceo
Mr. Thomas J. Langan
Address
222 Merchandise Mart Plaza
City
Chicago
State
IL
Zip
60654
Country
United States
Phone
800 334 8534
